ODC web page reads as below: "Provided domestic supply of...

ODC web page reads as below:
"Provided domestic supply of medicinal cannabis is not affected, the following products are eligible for export if granted a licence and permit to export"
source: https://www.odc.gov.au/import-and-export

Australian market first, then you are allowed to export to other countries. But as Australia only has a population of 25m ppl, and the percentage of patience requiring MM treatment is very small, which means Australian MM players all have to rely heavily on exporting their products.

In my opinion, the Australian MM products will penetrate US/Canadian and Asian market as Australian agricultural products are seen as unpolluted and clean products compared to the products grown and manufactured in other parts of the world. One example is the beef exporting market, US is the biggest exporter of beef, but many Asian countries prefer to consume Australian beef when and if available. Also, another example is the Australian Baby formula companies such as A2M, Ballemys and BUB. Also, Asian countries will import Australian CBD/THC products as we saw in case of Varm Cosmo signing import contract with MGC.

Anyway, the main concern with SCU is the company's management style and the transparency of the business. Since 2017 announcement of Schoenmakers news, the company has been extremely quiet. Also, there was a brief mentioning of JV with Israeli MM player, but even that is in the cloud and nothing has materialized in any contract form. If SCU can go ahead with JV with Israeli MM player soon and communicate clearly to the market on company's future direction in relation to MM/MC, then the share price will move up quickly. SCU could be the cheapest and the last value MM stock on ASX at this price currently. Of course, there is also QBL but that's another Day Traders's goat and being mining company, it simply has too many issued shares to have x times upside. All IMO.